Human BRD2 knockout HEK-293T cell lysate
Be the first to review this product! Submit a review
|
(0 Publication)
BRD2 KO cell lysate available now. KO validated by Western blot. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon7 and 1 bp insertion in exon7 and 22 bp deletion in exon7.
View Alternative Names
BRD2_HUMAN, Bromodomain containing 2, Bromodomain-containing protein 2, D6S113E, DKFZp686N0336, FLJ31942, FSH, FSRG1, Female sterile homeotic related gene 1, Female sterile homeotic related gene 1, mouse, homolog of, KIAA9001, NAT, O27.1.1, RING3, RING3 PROTEIN, RNF3, Really interesting new gene 3 protein
- WB
Lab
Western blot - Human BRD2 knockout HEK-293T cell lysate (AB257191)
Lane 1 : Wild-type HEK293T cell lysate (20 ug)
Lane 2 : BRD2 knockout HEK293T cell lysate (20 ug)
Lane 3 : HeLa cell lysate (20 ug)
ab139690 was shown to specifically react with BRD2 in wild-type HEK293T cells. Loss of signal was observed when knockout cell line ab267265 (knockout cell lysate ab257191) was used. Wild-type and BRD2 knockout samples were subjected to SDS-PAGE. ab139690 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated at room temperature for 2.5 hours at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-BRD2 antibody [EPR7642] - ChIP Grade (<a href='/en-us/products/primary-antibodies/brd2-antibody-epr7642-chip-grade-ab139690'>ab139690</a>) at 1/1000 dilution
Lane 1:
Wild-type HEK293T cell lysate at 20 µg
Lane 2:
BRD2 knockout HEK293T cell lysate at 20 µg
Lane 2:
Western blot - Human BRD2 knockout HEK-293T cell line (<a href='/en-us/products/cell-lines/human-brd2-knockout-hek-293t-cell-line-ab267265'>ab267265</a>)
Lane 3:
HeLa cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-800cw-preadsorbed-ab216773'>ab216773</a>) at 1/10000 dilution
Predicted band size: 126 kDa,19 kDa,20 kDa,26 kDa,32 kDa,34 kDa,44 kDa,88 kDa
Observed band size: 110 kDa,26 kDa,50 kDa
false
- WB
Lab
Western blot - Human BRD2 knockout HEK-293T cell lysate (AB257191)
Lane 1 : Wild-type HEK293T cell lysate (20 ug)
Lane 2 : BRD2 knockout HEK293T cell lysate (20 ug)
Lane 3 : HeLa cell lysate (20 ug)
ab243865 was shown to specifically react with BRD2 in wild-type HEK293T cells. Loss of signal was observed when knockout cell line ab267265 (knockout cell lysate ab257191) was used. Wild-type and BRD2 knockout samples were subjected to SDS-PAGE. ab243865 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated at room temperature for 2.5 hours at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-BRD2 antibody [BL-167-2A2] (<a href='/en-us/products/primary-antibodies/brd2-antibody-bl-167-2a2-ab243865'>ab243865</a>) at 1/1000 dilution
Lane 1:
Wild-type HEK293T cell lysate at 20 µg
Lane 2:
BRD2 knockout HEK293T cell lysate at 20 µg
Lane 2:
Western blot - Human BRD2 knockout HEK-293T cell line (<a href='/en-us/products/cell-lines/human-brd2-knockout-hek-293t-cell-line-ab267265'>ab267265</a>)
Lane 3:
HeLa cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-800cw-preadsorbed-ab216773'>ab216773</a>) at 1/10000 dilution
Predicted band size: 88 kDa
Observed band size: 110 kDa
false
- Sanger seq
Unknown
Sanger Sequencing - Human BRD2 knockout HEK-293T cell lysate (AB257191)
Allele-2 : 1 bp deletion in exon7
- Sanger seq
Unknown
Sanger Sequencing - Human BRD2 knockout HEK-293T cell lysate (AB257191)
Allele-3 : 1 bp insertion in exon7
- Sanger seq
Unknown
Sanger Sequencing - Human BRD2 knockout HEK-293T cell lysate (AB257191)
Allele-1 : 22 bp deletion in exon7
Reactivity data
Product details
Knockout cell lysate achieved by CRISPR/Cas9.
REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.
Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.
User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.
This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.
What's included?
Properties and storage information
Gene name
Gene editing type
Gene editing method
Knockout validation
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Quality control
STR analysis
CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX
Cell culture
Biosafety level
EU: 2 US: 2
Adherent/suspension
Adherent
Gender
Female
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com